| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_818b9f44d2a27de5abc507b49cf1bf85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31f05931c4ac224ef8e931d40da6125a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-683 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-54 |
| filingDate |
2017-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72ac080fcce517fedc7a53f4b579020d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77dceabfd2ad22234996d3ecc0672d1e |
| publicationDate |
2018-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201801734-A |
| titleOfInvention |
Safe and stable plasmalogen and its preparation and method for judging the disease state of dementia |
| abstract |
The object of the present invention is to provide a safe and stable plasmalogen and its preparation, and a method for determining a disease-free state of dementia.nn n n A biological tissue-specific composition ratio derived from living tissue, which is extracted and separated from its specific parts and internal organs, and is composed of all lipids purified by removing by-products and water-soluble low-molecular-weight lipids. A complex lipid of plasmalogen; a composition that is specific to living tissues by enzymatically treating the complex lipid with phospholipase A1 (PLA1), removing glycerophospholipids containing lysosomes, and extracting and removing sphingomyelin. Method for purifying plasmalogens and the like; a method of using omega-3HUFA-bound purified plasmalogens and the like as an active ingredient as a nutritional supplement for preventing dementia or a processed food produced by the method; And a preparation for treating a neurodegenerative disease and / or a mental disease, and a method for judging the non-disease state of dementia. |
| priorityDate |
2016-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |